Labiotre Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 22

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 3

Labiotre General Information

Description

Provider of botanical extracts intended to cater to professionals. The company's products include fermented ingredients, composed extracts, phytobilayer, verbascox, plant buds, and soft gel, enabling customers to choose the most appropriate category for the final preparation among the different categories of products offered.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Via Renato Guttuso, 6
  • Loc. Sambuca Val di Pesa Tavarnelle Val di Pesa
  • 50028 Florence(Tavarnelle Val di Pesa)
  • Italy
+39 055
Primary Industry
Other Commercial Services
Other Industries
Pharmaceuticals
Parent Company
Vertical(s)
Corporate Office
  • Via Renato Guttuso, 6
  • Loc. Sambuca Val di Pesa Tavarnelle Val di Pesa
  • 50028 Florence(Tavarnelle Val di Pesa)
  • Italy
+39 055

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Labiotre Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Labiotre‘s full profile, request access.

Request a free trial

Labiotre Patents

Labiotre Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4153143-A1 Process for preparing an active liposome, related compositions and uses Pending 18-May-2020
WO-2021234538-A1 Process for preparing an active liposome, related compositions and uses Inactive 18-May-2020
EP-3996814-A1 Use of a herbal extract comprising verbascoside and aucubin for the treatment of osteoarthritis of the knee Active 11-Jul-2019
EP-3996814-B1 Use of a herbal extract comprising verbascoside and aucubin for the treatment of osteoarthritis of the knee Active 11-Jul-2019
EP-3996814-C0 Use of a herbal extract comprising verbascoside and aucubin for the treatment of osteoarthritis of the knee Active 11-Jul-2019 A61P29/00
To view Labiotre’s complete patent history, request access »

Labiotre Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Labiotre Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Labiotre‘s full profile, request access.

Request a free trial

Labiotre FAQs

  • When was Labiotre founded?

    Labiotre was founded in 2011.

  • Where is Labiotre headquartered?

    Labiotre is headquartered in Florence, Italy.

  • What is the size of Labiotre?

    Labiotre has 22 total employees.

  • What industry is Labiotre in?

    Labiotre’s primary industry is Other Commercial Services.

  • Is Labiotre a private or public company?

    Labiotre is a Private company.

  • What is the current valuation of Labiotre?

    The current valuation of Labiotre is .

  • What is Labiotre’s current revenue?

    The current revenue for Labiotre is .

  • Who are Labiotre’s investors?

    BioDue has invested in Labiotre.

  • When was Labiotre acquired?

    Labiotre was acquired on 23-Nov-2021.

  • Who acquired Labiotre?

    Labiotre was acquired by Labomar.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process